- Market Cap ₹ 3,941 Cr.
- Current Price ₹ 490
- High / Low ₹ 535 / 235
- Stock P/E 29.2
- Book Value ₹ 101
- Dividend Yield 0.12 %
- ROCE 21.8 %
- ROE 15.7 %
- Face Value ₹ 2.00
- Industry PE 34.6
- Promoter
holding 68.3 %
- Pledged
percentage 0.00 %
- Debt to equity 0.01
- Profit Prev 12M ₹ 119 Cr.
- EPS ₹ 16.8
- Price to book
value 4.84
- EVEBITDA 19.2
- Price to
Earning 29.2
- No. Eq. Shares 8.05
- Change in Prom Hold 0.00 %
Introduction
Supriya Life Science Limited is a notable player in the Indian pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. Since its establishment in 2008, the company has positioned itself as a significant global player through its commitment to quality, innovation, and expansive market reach. This analysis explores Supriya Life Science's fundamental and technical aspects, providing insights into its operational performance, market positioning, and investment potential.
Fundamental Analysis
1. Company Overview and Business Model
Supriya Life Science specializes in manufacturing APIs and intermediates across various therapeutic areas, including anti-allergics, anti-hypertensives, and anti-psychotics. The company operates state-of-the-art manufacturing facilities in India, adhering to global quality standards such as US FDA, EU GMP, and WHO GMP certifications. This commitment to high-quality production ensures its products meet international standards, facilitating a strong presence in global markets.
2. Financial Performance
Revenue Growth: Supriya Life Science has exhibited consistent revenue growth, reflecting its successful expansion into international markets and its ability to cater to diverse therapeutic needs. The company’s revenue trajectory indicates robust market demand for its products.
Profitability: The company maintains healthy profit margins and demonstrates strong earnings before interest, taxes, depreciation, and amortization (EBITDA). Profitability is driven by efficient operations, cost management, and a growing product portfolio.
Balance Sheet Strength: Supriya Life Science’s balance sheet shows a solid financial position with manageable levels of debt. Key liquidity ratios, such as the current ratio and quick ratio, indicate the company’s ability to cover short-term liabilities. Additionally, the company’s low leverage and strong equity base suggest financial stability and minimal risk.
Cash Flow: Positive operating cash flow highlights the company’s ability to generate sufficient cash from its core operations. This financial stability supports ongoing investments in R&D and capacity expansion.
3. Market Position and Competitive Advantage
Product Portfolio: Supriya Life Science’s diverse portfolio across various therapeutic areas provides a competitive edge. The company’s focus on high-quality APIs and regulatory compliance enhances its reputation and market competitiveness.
Global Reach: The company’s international presence in markets such as the United States, Europe, and Asia demonstrates its effective global strategy. Strategic partnerships and collaborations further bolster its market position and facilitate entry into new markets.
Research and Development (R&D): Supriya Life Science invests significantly in R&D, which is crucial for innovation and maintaining a competitive edge. The company’s R&D capabilities focus on developing new APIs and optimizing existing processes, driving future growth and product differentiation.
4. Industry Trends and Regulatory Environment
Pharmaceutical Industry Growth: The pharmaceutical industry is experiencing growth due to increasing healthcare demands, an aging population, and advancements in drug development. Supriya Life Science is well-positioned to benefit from these trends through its comprehensive product range and R&D focus.
Regulatory Compliance: Compliance with stringent international regulations is critical for pharmaceutical companies. Supriya Life Science’s adherence to global quality standards minimizes regulatory risks and enhances its credibility in international markets.
Technical Analysis
1. Stock Performance and Price Trends
Historical Price Movements: Supriya Life Science’s stock price has shown growth over time, reflecting positive investor sentiment and the company’s financial performance. Analyzing historical price data reveals patterns of upward momentum and periods of volatility.
Moving Averages: Moving averages, such as the 50-day and 200-day moving averages, help identify trends. A crossover of the short-term moving average above the long-term moving average typically signals a bullish trend, while the opposite crossover may indicate a bearish trend.
2. Technical Indicators
Relative Strength Index (RSI): The RSI measures the speed and change of price movements. An RSI above 70 suggests the stock may be overbought, indicating a potential reversal, while an RSI below 30 suggests the stock may be oversold, potentially signaling a buying opportunity.
Moving Average Convergence Divergence (MACD): The MACD indicator helps identify changes in momentum and trend direction. Positive MACD values indicate a bullish trend, while negative values suggest a bearish trend.
Bollinger Bands: Bollinger Bands consist of a moving average and two standard deviation lines. Prices moving outside these bands can indicate potential trend reversals or continuation patterns. Analyzing how the stock price interacts with these bands provides insights into volatility and market sentiment.
3. Volume Analysis
Trading Volume: Volume analysis helps confirm price trends. Increasing volume during an uptrend suggests strong investor interest and confidence, while decreasing volume may indicate weakening momentum or potential trend reversal.
4. Support and Resistance Levels
Support Levels: Historical support levels are points where buying interest may emerge, providing potential price floors. Observing these levels helps gauge where the stock might find support if it declines.
Resistance Levels: Resistance levels are price points where selling pressure typically emerges. Identifying these levels helps understand potential price ceilings and where the stock might face challenges in advancing.
5. Market Sentiment and External Factors
Economic Indicators: Broader economic conditions, such as GDP growth, inflation rates, and interest rates, influence stock performance. Positive economic conditions generally support market growth, while adverse conditions can lead to market downturns.
Industry News: News related to regulatory changes, drug approvals, and industry developments can impact Supriya Life Science’s stock performance. Staying informed about industry trends and news helps assess potential price movements and investment decisions.
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 19.4%